Aspirin-exacerbated respiratory disease: characteristics and management strategies

References

• Widal F, Abrami P, Lermoyez J. Anaphylaxie et idiosyncrasie. Presse Med 1922;30:189-93
   Google Scholar
• Samter M, Beers RFJr. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern med 1968;68:975-83
   PubMed Web of Science ®Google Scholar
• Szczeklik A, Nizankowska-Mogilnicka E, Sanak M. Hypersensitivity to aspirin and non-steroidal anti-inflammatory drugs. In: Adkinson NFJr, Bochner BS, Busse WW, et al. editors. Middleton’s allergy: principles and practice. 7th edition. Mosby; New York: 2009. p. 1227-40
   Google Scholar
• Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004;328:434
   PubMed Web of Science ®Google Scholar
• Vally H, Taylor ML, Thompson PJ. The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients. Thorax 2002;57:569-74
   PubMedGoogle Scholar
• Hedman J, Kaprio J, Poussa T, et al. Prevalence of asthma, aspirin intolerance, nasal polyposis, and chronic obstructive pulmonary disease in a population based study. Int J Epidemiol 1999;28:717-22
   PubMed Web of Science ®Google Scholar
• Kasper L, Sladek K, Duplaga M, et al. Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland. Allergy 2003;58:1064-6
   PubMed Web of Science ®Google Scholar
• Szczeklik A, Nizankowska-Mogilnicka E, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 2000;16:432-6
   PubMed Web of Science ®Google Scholar
• Ledford D, Wenzel S, Lockey R. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma. J Allergy Clin Immunol Pract 2014;2:653-7
   PubMed Web of Science ®Google Scholar
• Zeiss C, Lockey R. Refractory period to aspirin in a patient with aspirin-induced asthma. J Allergy Clin Immunol 1976;57:440-8
   PubMed Web of Science ®Google Scholar
• Drusun A, Woessner K, Simon R, et al. Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis. Ann Allergy Asthma Immunol 2008;100:420-5
   Google Scholar
• Rajan J, Wineinger N, Stevenson D, et al. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature. J Allergy Clin Immunol 2015;135(3):676-81
   PubMed Web of Science ®Google Scholar
• Berges-Gimeno MP, Simon RA, Stevenson DD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2002;89:474-8
   PubMed Web of Science ®Google Scholar
• Young J, Frenkiel S, Tewfik MA, et al. Long-term outcome analysis of endoscopic sinus surgery for chronic sinusitis. Am J Rhinol 2007;21:743-7
   PubMedGoogle Scholar
• Kim JE, Kountakis SE. The prevalence of Samter’s triad in patients undergoing functional endoscopic sinus surgery. Ear Nose Throat J 2007;86:396-9
   PubMed Web of Science ®Google Scholar
• Mascia D, Haselkorn T, Deniz Y, et al. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult to treat asthma. J Allergy Clin Immunol 2005;116:970-5
   PubMed Web of Science ®Google Scholar
• Amar YG, Frenkiel S, Sobol SE. Outcome analysis of endoscopic sinus surgery for chronic sinusitis in patients having Samter’s triad. J Otolaryngol 2000;29:7-12
   PubMedGoogle Scholar
• Batra PS, Kern RC, Tripathi A, et al. Outcome analysis of endoscopic sinus surgery in patients with nasal polyps and asthma. Laryngoscope 2003;113:1703-6
   PubMed Web of Science ®Google Scholar
• Janti-Alanko S, Holopainen E, Malmberg H. Recurrence of nasal polyps after surgical treatment. Rhinol Suppl 1989;8:59-64
   Google Scholar
• McFadden EA, Kany RJ, Fink JN, et al. Surgery for sinusitis and aspirin triad. Laryngoscope 1990;100:1043-6
   PubMed Web of Science ®Google Scholar
• McMains KC, Kountakis SE. Medical and surgical considerations in patients with Samter’s triad. Am J Rhinol 2006;20:573-6
   PubMedGoogle Scholar
• Vento SI, Ertama LO, Hytonen ML, et al. Nasal polyposis: clinical course during 20 years. Ann Allergy Asthma Immunol 2000;85:209-14
   PubMed Web of Science ®Google Scholar
• Stevenson D, Simon R, Zuraw B. Sensitivity to aspirin and NSAIDs. In: Adkinson NJ, Yunginger J, Busse W, et al. editors. Middleton’s allergy: principles and practice. 6th edition. Mosby; Philadelphia: 2003. p. 1695-710
   Google Scholar
• Stevenson D. Aspirin and NSAID sensitivity. Immunol Allergy Clin North Am 2004;24:491-505, vii
   PubMed Web of Science ®Google Scholar
• Woessner K, White A. Evidence-based approach to aspirin desensitization in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2013;133:286-7
   Google Scholar
• Fahrenholz JM. Natural history and clinical features of aspirin-exacerbated respiratory disease. Clin Rev Allergy Immunol 2003;24:113-24
   PubMed Web of Science ®Google Scholar
• Stevenson D. Aspirin sensitivity and desensitization for asthma and sinusitis. Curr Allergy Asthma Rep 2009;9:155-63
   PubMed Web of Science ®Google Scholar
• Stevenson D, Hougham A, Schrank P, et al. Disalcid cross-sensitivity in aspirin sensitive asthmatics. J Allergy Clin Immunol 1990;86:749-58
   PubMed Web of Science ®Google Scholar
• Settipane R, Stevenson D. Cross sensitivity with acetaminophen in aspirin sensitive asthmatics. J Allergy Clin Immunol 1989;84:26-33
   PubMed Web of Science ®Google Scholar
• Bavbek S, Celik G, Ediger D, et al. The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal anti-inflammatory drug intolerance. J Asthma 1999;36:657-63
   PubMed Web of Science ®Google Scholar
• Vaghi A. Tolerance of meloxicam in aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1998;157:715
   PubMedGoogle Scholar
• Gyllfors P, Bochenek G, Overholt J, et al. Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgesic drug celecoxib. J Allergy Clin Immunol 2003;111:1116-21
   PubMed Web of Science ®Google Scholar
• Szczeklik A, Nizankoska E, Bochenek G, et al. Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy 2001;31:219-25
   PubMed Web of Science ®Google Scholar
• Stevenson D, Simon R. Lack of cross-reactivity between rofecoxib and aspirin in aspirin sensitive asthmatic patients. J Allergy Clin Immunol 2001;108:47-51
   PubMedGoogle Scholar
• Woessner K, Simon R, Stevenson D. The safety of celecoxib in aspirin exacerbated respiratory disease. Arthritis Rheum 2002;46:2201-6
   PubMed Web of Science ®Google Scholar
• Milewski M, Mastalerz L, Nizankowska E, et al. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol 1998;101:581-6
   PubMed Web of Science ®Google Scholar
• Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin sensitivity. Allergy 2007;62:1111-18
   PubMed Web of Science ®Google Scholar
• White A, Bigby T, Stevenson D. Intranasal ketorolac challenge for the diagnosis of aspirin exacerbated respiratory disease. Ann Allergy Asthma Immunol 2006;97:190-5
   PubMed Web of Science ®Google Scholar
• Lee R, White A, Ding D, et al. Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2010;105(2):130-5
   PubMed Web of Science ®Google Scholar
• White AA, Bosso JV, Stevenson DD. The clinical dilemma of “silent desensitization” in aspirin-exacerbated respiratory disease. Allergy Asthma Proc 2013;34:378-82
   PubMed Web of Science ®Google Scholar
• Mullol J, Picado C. Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease. Immunol Allergy Clin North Am 2013;33:163-76
   PubMed Web of Science ®Google Scholar
• Bachert C, Zhang N. Chronic rhinosinusitis and asthma: novel understanding of the role of IgE ’above atopy’. J Intern Med 2012;272:133-43
   PubMed Web of Science ®Google Scholar
• Payne S, Early S, Huyett P, et al. Evidence for distinct presentations of nasal polyps: with and without eosinophilia. Laryngoscope 2011;121:2262-7
   Google Scholar
• Mascia K, Borish L, Patrie J, et al. Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2005;94:652-7
   PubMed Web of Science ®Google Scholar
• Perez-Novo CA, Watelet JB, Claeys C, et al. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J Allergy Clin Immunol 2005;115:1189-96
   PubMed Web of Science ®Google Scholar
• Choi GS, Kim JH, Shin YS, et al. Eosinophil activation and novel mediators in the aspirin-induced nasal response in AERD. Clin Exp Allergy 2013;43:730-40
   PubMed Web of Science ®Google Scholar
• Steinke JW, Liu L, Huyett P, et al. Prominent role of IFN-[gamma] in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2013;132:856-65
   Google Scholar
• Steinke JW, Negri J, Liu L, et al. Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease. J Immunol 2014;193:41-7
   Google Scholar
• Laidlaw TM, Kidder MS, Bhattacharyya N, et al. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood 2012;119:3790-8
   PubMed Web of Science ®Google Scholar
• Samuelsson B. Arachidonic acid metabolism: role in inflammation. Rheumatol 1991;50(Suppl 1):3-6
   Google Scholar
• Kanaoka Y, Boyce JA. Cysteinyl leukotrienes and their receptors; emerging concepts. Aller gy Asthma Immunol Res 2014;6:288-95
   PubMed Web of Science ®Google Scholar
• Adamusiak AM, Stasikowska-Kanicka O, Lewandowska-Polak A, et al. Expression of arachidonate metabolism enzymes and receptors in nasal polyps of aspirin-hypersensitive asthmatics. Int Arch Allergy Immunol 2011;157:354-62
   Google Scholar
• Corrigan C, Mallett K, Ying S, et al. Expression of the cysteinyl leukotriene receptors cysLT(1) and cysLT(2) in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis. J Allergy Clin Immunol 2005;115:316-22
   PubMedGoogle Scholar
• Sousa AR, Parikh A, Scadding G, et al. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002;347:1493-9
   PubMed Web of Science ®Google Scholar
• Higashi N, Taniguchi M, Mita H, et al. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): involvement of chronic hyperplastic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol 2004;113:277-83
   PubMed Web of Science ®Google Scholar
• Roca-Ferrer J, Garcia-Garcia FJ, Pereda J, et al. Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma. J Allergy Clin Immunol 2011;128:66-72
   PubMed Web of Science ®Google Scholar
• Kowalski ML, Pawliczak R, Wozniak J, et al. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. Am J Respir Crit Care Med 2000;161:391-8
   PubMed Web of Science ®Google Scholar
• Picado C, Fernandez-Morata JC, Juan M, et al. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1999;160:291-6
   PubMedGoogle Scholar
• Liu T, Laidlaw TM, Feng C, et al. Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes. Proc Natl Acad Sci 2013;110:16987-92
   PubMed Web of Science ®Google Scholar
• Choi JH, Kim JH, Park HS. Upper airways in aspirin-exacerbated respiratory disease. Curr Opin Allergy Clin Immunol 2015;15:21-6
   PubMed Web of Science ®Google Scholar
• Stevenson DD. Aspirin desensitization in patients with AERD. Clin Rev Allergy Immunol 2003;24:159-68
   PubMed Web of Science ®Google Scholar
• Adappa ND, Wei CC, Palmer JN. Nasal irrigation with or without drugs: the evidence. Curr Opin Otolaryngol Head Neck Surg 2012;20:53
   Google Scholar
• Mastalerz L, Milewski M, Duplaga M, et al. Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients with aspirin-induced asthma. Allergy 1997;52:895-900
   PubMed Web of Science ®Google Scholar
• Hardy JG, Lee SW, Wilson CG. Intranasal drug delivery by spray and drops. J Pharm Pharmacol 1985;37:294
   PubMed Web of Science ®Google Scholar
• Dahlen S, Malstrom K, Nizankowska E, et al. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist. A randomized, double blind, placebo controlled trial. Am J Respir Crit Care Med 2002;165:9-14
   PubMed Web of Science ®Google Scholar
• Dahlen B. Treatment of aspirin-intolerant asthma with antileukotrienes. Am J Respir Crit Care Med 2006;161(Suppl):S137-41
   Google Scholar
• Berges-Gimeno MP, Simon RA, Stevenson DD. The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions. Clin Exp Allergy 2002;32:1491-6
   PubMed Web of Science ®Google Scholar
• White A, Ludington E, Mehra P, et al. Effect of leukotriene modifier drugs on the safety of oral aspirin challenges. Ann Allergy Asthma Immunol 2006;97:688-93
   PubMed Web of Science ®Google Scholar
• Wen W, Liu W, Zhang L, et al. Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy. J Allergy Clin Immunol 2012;129:1522
   PubMed Web of Science ®Google Scholar
• Awad OG, Lee JH, Fasano MB, et al. Sinonasal outcomes after endoscopic sinus surgery in asthmatic patients with nasal polyps: a difference between aspirin-tolerant and aspirin-induced asthma? Laryngoscope 2008;118(7):1282-6
   Google Scholar
• Stevenson DD, Simon RA. Selection of patients for aspirin desensitization treatment. J Allergy Clin Immunol 2006;118:801-4
   PubMed Web of Science ®Google Scholar
• Macy E, Bernstein JA, Castells MC, et al. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper. Ann Allergy Asthma Immunol 2007;98:172-4
   PubMed Web of Science ®Google Scholar
• Berges-Gimeno MP, Simon RA, Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2003;111:180-6
   PubMed Web of Science ®Google Scholar
• Stevenson DD, Hankammer MA, Mathison DA, et al. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long term outcomes. J Allergy Clin Immunol 1996;98:751-8
   PubMed Web of Science ®Google Scholar
• Kowalski ML, Grzelewska-Rzymowska I, Szmidt M, et al. Clinical efficacy of aspirin in “desensitized” aspirin-sensitive asthmatics. Eur J Respir Dis 1986;69:751-8
   Google Scholar
• Klimek L, Pfaar O. Aspirin intolerance: does desensitization alter the course of disease? Immunol Allergy Clin North Am 2009;29:669-75
   Google Scholar
• Shaker M, Lobb A, Jenkins P, et al. An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2008;121:81-7
   Google Scholar
• Hope AP, Woessner KA, Simon RA, et al. Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2009;123:406-10
   PubMed Web of Science ®Google Scholar
• Williams AN, Simon RA, Woessner KM, et al. The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges. J Allergy Clin Immunol 2007;120:273-7
   PubMed Web of Science ®Google Scholar
• Lee JY, Simon RA, Stevenson DD. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2007;119:157-64
   PubMed Web of Science ®Google Scholar
• Rozsasi, et al. Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily. Allergy 2008;63:1228-34
   PubMed Web of Science ®Google Scholar
• Lee RU, Stevenson DD. Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res 2011;3:3-10
   PubMed Web of Science ®Google Scholar
• Berges-Gimeno P, Simon RA, Stevenson DD. Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2003;90:338-41
   PubMed Web of Science ®Google Scholar
• Cho KS, Soudry E, Psaltis AJ, et al. Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease. Otolaryngol Head Neck Surg 2014;151(4):575-81
   PubMed Web of Science ®Google Scholar
• Havel M, Ertl L, Braunschweig F, et al. Sinonasal outcome under aspirin desensitization following functional endoscopic sinus surgery in patients with aspirin triad. Eur Arch Otorhinolaryngol 2012;270(2):571-8
   Google Scholar
• Forer B, Kivity S, Sade J, et al. Aspirin desensitization for ASA triad patients – prospective study of the rhinologist’s perspective. Rhinology 2011;49(1):95-9
   Web of Science ®Google Scholar